BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38515278)

  • 41. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
    Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
    J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy.
    Li J; Yuan J; Li Y; Wang J; Xie Q; Ma R; Wang J; Ren M; Lu D; Xu Z
    Phytomedicine; 2022 Nov; 106():154411. PubMed ID: 36030746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.
    Ping S; Wang S; Zhao Y; He J; Li G; Li D; Wei Z; Chen J
    Cancer Med; 2022 Sep; 11(18):3529-3541. PubMed ID: 35373463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
    Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S
    Front Oncol; 2024; 14():1344290. PubMed ID: 38469234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis.
    Igarashi K; Nishizawa H; Saiki Y; Matsumoto M
    J Biol Chem; 2021 Sep; 297(3):101032. PubMed ID: 34339740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epithelial-to-mesenchymal-like transition events in melanoma.
    Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
    FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.
    Marsan M; Van den Eynden G; Limame R; Neven P; Hauspy J; Van Dam PA; Vergote I; Dirix LY; Vermeulen PB; Van Laere SJ
    PLoS One; 2014; 9(2):e89262. PubMed ID: 24586640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/β-catenin signaling.
    He W; He S; Wang Z; Shen H; Fang W; Zhang Y; Qian W; Lin M; Yuan J; Wang J; Huang W; Wang L; Ke Z
    BMC Cancer; 2015 Mar; 15():107. PubMed ID: 25880337
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eriocitrin inhibits epithelial-mesenchymal transformation (EMT) in lung adenocarcinoma cells via triggering ferroptosis.
    Gao M; Lai K; Deng Y; Lu Z; Song C; Wang W; Xu C; Li N; Geng Q
    Aging (Albany NY); 2023 Oct; 15(19):10089-10104. PubMed ID: 37787987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrin alpha-2 and beta-1 expression increases through multiple generations of the EDW01 patient-derived xenograft model of breast cancer-insight into their role in epithelial mesenchymal transition in vivo gained from an in vitro model system.
    Wafai R; Williams ED; de Souza E; Simpson PT; McCart Reed AE; Kutasovic JR; Waltham M; Snell CE; Blick T; Thompson EW; Hugo HJ
    Breast Cancer Res; 2020 Dec; 22(1):136. PubMed ID: 33276802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy.
    Ebrahimi N; Adelian S; Shakerian S; Afshinpour M; Chaleshtori SR; Rostami N; Rezaei-Tazangi F; Beiranvand S; Hamblin MR; Aref AR
    Cytokine Growth Factor Rev; 2022 Apr; 64():33-45. PubMed ID: 35219587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial-mesenchymal transition inhibition by metformin reduces melanoma lung metastasis in a murine model.
    Veloso ES; de Carvalho BA; de Souza Silva FH; Ribeiro TS; Lima BM; Almeida CP; da Silva VHSR; Rocha SA; de Araújo Campos MR; Del Puerto HL; Ferreira E
    Sci Rep; 2022 Oct; 12(1):17776. PubMed ID: 36273071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
    Tachtsidis A; Le AV; Blick T; Gunasinghe D; De Sousa E; Waltham M; Dobrovic A; Thompson EW
    Clin Exp Metastasis; 2019 Aug; 36(4):393-409. PubMed ID: 31190270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis.
    Gagliardi M; Cotella D; Santoro C; Corà D; Barlev NA; Piacentini M; Corazzari M
    Cell Death Dis; 2019 Nov; 10(12):902. PubMed ID: 31780644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma.
    Liu Y; Chu Z; Li Q; Peng B; Xu S; Lian CG; Geng S
    Oncol Rep; 2017 Jan; 37(1):139-146. PubMed ID: 27878257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.
    Jinesh GG; Brohl AS
    Signal Transduct Target Ther; 2022 Aug; 7(1):296. PubMed ID: 35999218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
    Liu Z; Wang J; Li S; Li L; Li L; Li D; Guo H; Gao D; Liu S; Ruan C; Dang X
    Front Immunol; 2022; 13():1076045. PubMed ID: 36591279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression.
    Horny K; Sproll C; Peiffer L; Furtmann F; Gerhardt P; Gravemeyer J; Stoecklein NH; Spassova I; Becker JC
    J Transl Med; 2023 Apr; 21(1):267. PubMed ID: 37076857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
    Chen WY; Xu YY; Zhang XY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.